Guizhou Sanli Pharmaceutical Co., Ltd. announced that Guangshenghaitong Minqi High-quality Development Fund, a shareholder holding more than 5% of the shares of the company, implemented a shareholding reduction plan. By means of centralized bidding, 9,900 shares of the company were reduced, and the post-shareholding amount is 20,490,100 shares, accounting for 4.999997% of the total share capital of the company. It is no longer a shareholder holding more than 5% of the company. This equity change does not trigger a mandatory takeover and will not cause any changes to the actual controller of the company.
贵州三力：持股5%以上股东减持至5%以下
Guizhou Sanli Pharmaceutical Co., Ltd.: Shareholders holding more than 5% of shares have reduced their shareholding to below 5%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated